000168844 001__ 168844
000168844 005__ 20240229133620.0
000168844 0247_ $$2doi$$a10.1177/17588359211006348
000168844 0247_ $$2ISSN$$a1758-8340
000168844 0247_ $$2ISSN$$a1758-8359
000168844 0247_ $$2altmetric$$aaltmetric:106101096
000168844 037__ $$aDKFZ-2021-01095
000168844 082__ $$a610
000168844 1001_ $$0P:(DE-He78)657300dfd28903ec8149ca9bf5e7968d$$aBoakye, Daniel$$b0$$eFirst author
000168844 245__ $$aEarly discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
000168844 260__ $$aThousand Oaks, Calif.$$bSage$$c2021
000168844 3367_ $$2DRIVER$$aarticle
000168844 3367_ $$2DataCite$$aOutput Types/Journal article
000168844 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1637158582_23141
000168844 3367_ $$2BibTeX$$aARTICLE
000168844 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000168844 3367_ $$00$$2EndNote$$aJournal Article
000168844 500__ $$a#EA:C070#LA:C070# /2021, Vol. 13: 1–18
000168844 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000168844 588__ $$aDataset connected to CrossRef, Journals: inrepo01.inet.dkfz-heidelberg.de
000168844 7001_ $$0P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aJansen, Lina$$b1$$udkfz
000168844 7001_ $$0P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601$$aHalama, Niels$$b2$$udkfz
000168844 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang-Claude, Jenny$$b3$$udkfz
000168844 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b4$$udkfz
000168844 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$eLast author$$udkfz
000168844 773__ $$0PERI:(DE-600)2503443-1$$a10.1177/17588359211006348$$gVol. 13, p. 175883592110063 -$$p1-18$$tTherapeutic advances in medical oncology$$v13$$x1758-8359$$y2021
000168844 909CO $$ooai:inrepo02.dkfz.de:168844$$pVDB
000168844 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)657300dfd28903ec8149ca9bf5e7968d$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000168844 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000168844 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000168844 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000168844 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000168844 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000168844 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000168844 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000168844 9141_ $$y2021
000168844 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz$$d2021-01-26$$wger
000168844 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-26$$wger
000168844 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bTHER ADV MED ONCOL : 2019$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-01-26
000168844 915__ $$0LIC:(DE-HGF)CCBYNCNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial CC BY-NC (No Version)$$bDOAJ$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bTHER ADV MED ONCOL : 2019$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-26
000168844 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-26
000168844 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000168844 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000168844 9201_ $$0I:(DE-He78)D240-20160331$$kD240$$lTranslationale Immuntherapie$$x2
000168844 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x3
000168844 980__ $$ajournal
000168844 980__ $$aVDB
000168844 980__ $$aI:(DE-He78)C070-20160331
000168844 980__ $$aI:(DE-He78)C120-20160331
000168844 980__ $$aI:(DE-He78)D240-20160331
000168844 980__ $$aI:(DE-He78)C020-20160331
000168844 980__ $$aUNRESTRICTED